Efekat hirurškog lečenja morbidne gojaznosti na funkcionalni kapacitet i faktore rizika za kardiovaskularne bolesti

  • Andrea B Manojlović Univerzitet u Beogradu, Medicinski fakultet
  • Andrea Lj Malešević Univerzitet u Beogradu, Medicinski fakultet
  • Ivana Nedeljković Klinički centar Srbije, Kabinet za kardiometaboličku neinvazivnu funkcionalnu dijagnostiku – ergospirometrija

Sažetak


Uvod: Morbidna gojaznost je povezana sa povišenim rizikom od kardiovaskularnih bolesti (KVB). Barijatrijska hirurgija je najefektivnija metoda za smanjenje telesne težine kod morbidno gojaznih osoba.                                                                                                                              Cilj rada: Ispitati efekat hirurškog lečenja morbidne gojaznosti na funkcionalni kapacitet i faktore rizika za KVB.                                                                                                                            Materijal i metode: U grupi od 56 morbidno gojaznih pacijenata upoređivane su vrednosti Body Mass Index-a (BMI), funkcionalni kapacitet i faktori rizika za KVB pre i 6 meseci nakon laparoskopskog bajpasa želuca. BMI je izračunat na osnovu podataka o telesnoj visini i telesnoj težini pacijenata. Parametri funkcionalnog kapaciteta (peak VO2 i VE/VCO2 slope) i vrednosti sistolnog (SKP) i dijastolnog (DKP) krvnog pritiska su dobijeni metodom ergospirometrije. Informacije o faktorima rizika za KVB dobijene su putem anamnestičkih podataka i laboratorijskih ispitivanja.                                                                                   Rezultati: Uočena je statistički značajna razlika u peak VO2 (p<0,0001) i VE/VCO2 slope (p =0,003) izmerenih pre i 6 meseci nakon operacije. Vrednosti SKP u mirovanju su se smanjile (p=0,017), kao i SKP pri maksimalnom naporu (p<0,0001). Slični rezultati su dobijeni su i upoređivanjem DKP u miru i DKP pri maksimalnom naporu (p<0,0001 i p=0,002, respektivno) pre i posle operacije. Smanjena je učestalost faktora rizika za KVB – hiperholesterolemije (12,5% vs 9%), dijabetesa (37% vs 19,6%) i hipertenzije (48,2% vs 33%).                                                                                                                             Zaključak: Morbidno gojazni pacijenti su pokazali poboljšanje funkcionalnog kapaciteta kao i korekciju faktora rizika za KVB 6 meseci nakon laparoskopskog bajpasa želuca.

Ključne reči: morbidna gojaznost, hirurgija, funkcionalni kapacitet

Reference

Mićić D, Stokić E, Antić S, Ratković S, Popović V. Gojaznost - Nacionalni vodič za lekare opšte prakse. Beograd : Izd. Medicinski fakultet Univerziteta u Beogradu CIBID - Centar za izdavačku, bibliotečku i informacionu delatnost, 2004.

World Health Organization. Obesity: preventing and managing the global epidemic. World Health Organization; 2000.

Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC public health. 2009 Mar 25;9(1):88.

Wilson PW, D'agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Archives of internal medicine. 2002 Sep 9;162(16):1867-72.

Pataky Z, Armand S, Müller Pinget S, Golay A, Allet L. Effects of obesity on functional capacity. Obesity. 2014 Jan 1;22(1):56-62.

Eckel RH American Heart Association. Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: executive summary/RH Eckel, DA York, S. Rossner. circulation. 2004;110(18):2968-75.

Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. European Journal of Endocrinology. 2008 Feb 1;158(2):135-45.

Costa RC, Yamaguchi N, Santo MA, Riccioppo D, Pinto-Junior PE. Outcomes on quality of life, weight loss, and comorbidities after Roux-en-Y gastric bypass. Arquivos de gastroenterologia. 2014 Sep;51(3):165-70.

Gallart-Aragón T, Fernández-Lao C, Castro-Martín E, Cantarero-Villanueva I, Cózar-Ibáñez A, Arroyo-Morales M. Health-Related Fitness Improvements in Morbid Obese Patients After Laparoscopic Sleeve Gastrectomy: a Cohort Study. Obesity Surgery. 2016 Oct 25:1-7.

Nedeljković I, Mazić S, Žugić V, Giga V, Dekleva M, Popović D, et al. Klinička primena kardiopulmonalnog testa fizičkim opterećenjem u savremenoj kardiologiji i posebnim grupama bolesnika. Srce i krvni sudovi 2012; 31(3): 166-173.

Nedeljković I, Dikić, izdavači i urednici. Stres test, Udruženje za sportsku kardiologiju Srbije, Beograd 2014.

Milani RV, Lavie CJ, Mehra MR, Ventura HO. Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc. 2006 Dec;81(12):1603-11.

Albouaini K, Egred M, Alahmar A, Wright DJ. Cardiopulmonary exercise testing and its application. Heart. 2007 Oct 1;93(10):1285-92.

Mezzani A, Agostoni P, Cohen-Solal A, Corra U, Jegier A, Kouidi E, et al. Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and Rehabilitation. European Journal of Cardiovascular Prevention & Rehabilitation. 2009 Jun;16(3):249-67.

Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Archives of internal medicine. 2001 Jul 9;161(13):1581-6.

Artham SM, Lavie CJ, Milani RV, Ventura HO. Obesity and hypertension, heart failure, and coronary heart disease—risk factor, paradox, and recommendations for weight loss. The Ochsner Journal. 2009 Sep;9(3):124-32.

Yusuf S, Hawken S, Ôunpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. The Lancet. 2005 Nov 11;366(9497):1640-9.

Kehagias I, Zygomalas A, Karavias D, Karamanakos S. Sleeve gastrectomy: have we finally found the holy grail of bariatric surgery? A review of the literature. European Review for Medical and Pharmacological Sciences. 2016 Dec;20:4930-42.

Hakala K, Mustajoki P, Aittomäki J, Sovijärvi A. Improved gas exchange during exercise after weight loss in morbid obesity. Clinical Physiology. 1996 May 1;16(3):229-38.

Serés L, Lopez Ayerbe J, Coll R, Rodriguez O, Vila J, Formiguera X, et al. Increased exercise capacity after surgically induced weight loss in morbid obesity. Obesity. 2006 Feb 1;14(2):273-9.

Brissman M, Ekbom K, Hagman E, Mårild S, Gronowitz E, Flodmark CE, et al. Physical fitness and body composition two years after roux-en-Y gastric bypass in adolescents. Obes Surg. 2017 Feb;27(2):330-337.

Kanoupakis E, Michaloudis D, Fraidakis O, Parthenakis F, Vardas P. Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity. Obesity surgery. 2001 Oct 1;11(5):552.

Carbajo MA, Fong-Hirales A, Luque-de-León E, Molina-Lopez JF, Ortiz-de-Solórzano J. Weight loss and improvement of lipid profiles in morbidly obese patients after laparoscopic one-anastomosis gastric bypass: 2-year follow-up. Surgical Endoscopy. 2017 Jan 1;31(1):416-21.

Mazidi M, Gao HK, Li L, Hui H, Ye Z. Effects of Roux-en-Y gastric bypass on insulin secretion and sensitivity, glucose homeostasis, and diabetic control: A prospective cohort study in Chinese patients. Surgery. 2017 Feb 21. pii: S0039-6060(16)30796-6.

Objavljeno
2017/12/30
Rubrika
Originalni naučni članak